Filing Details

Accession Number:
0000899243-20-018041
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-30 20:07:40
Reporting Period:
2020-06-26
Accepted Time:
2020-06-30 20:07:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419041 Forte Biosciences Inc. FBRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1339375 A Antony Riley C/O Forte Biosciences, Inc.
1124 W. Carson Street, Mrl Bldg. 3-320
Torrance CA 90502
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-26 4,700 $14.52 34,065 No 4 P Direct
Common Stock Acquisiton 2020-06-29 2,000 $14.11 36,065 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2020-06-30 75,000 $0.00 75,000 $14.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
75,000 2030-06-30 No 4 A Direct
Footnotes
  1. Represents the weighted average share price of an aggregate total of 4,700 shares purchased in the price range of $14.25 to $14.75 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2017 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 23, 2020.